Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
133,750,428
-
Share change
-
-395,043
-
Total reported value
-
$16,309,114,717
-
Put/Call ratio
-
202%
-
Price per share
-
$121.93
-
Number of holders
-
789
-
Value change
-
-$19,838,373
-
Number of buys
-
412
-
Number of sells
-
251
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2025
As of 31 Dec 2025,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
789 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,750,428 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, BNP PARIBAS FINANCIAL MARKETS, BANK OF AMERICA CORP /DE/, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, CITIGROUP INC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, JPMORGAN CHASE & CO, UBS Group AG, and Avoro Capital Advisors LLC.
This page lists
789
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.